Notes to Unaudited Consolidated Financial Statements
1. ORGANIZATION, BASIS OF PRESENTATION and RECENT ACCOUNTING PRONOUNCEMENTS
Organization
HV Bancorp, Inc., a Pennsylvania Corporation (the “Company”) is the holding company of Huntingdon Valley Bank (the “Bank”) and was formed in connection with the conversion of the Bank from the mutual to the stock form of organization. On January 11, 2017, the mutual to stock conversion of the Bank was completed and the Company became the parent holding company for the Bank. Shares of the Company began trading on the Nasdaq Capital Market on January 12, 2017. The Company is subject to regulation by the Board of Governors of the Federal Reserve System (the “Federal Reserve Bank”).
The Bank is a stock savings bank organized under the laws of the Commonwealth of Pennsylvania and is subject to comprehensive regulation and examination by the Federal Deposit Insurance Corporation (“FDIC”) and the Pennsylvania Department of Banking and Securities (“PADOB”). The Bank was organized in 1871, and currently provides residential and commercial loans to its general service area (Montgomery, Bucks and Philadelphia Counties of Pennsylvania and Wilmington County, Delaware) as well as offering a wide variety of savings, checking and certificate of deposit accounts to its retail and business customers.
Basis of Presentation
The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) for interim information and with the instructions to the Quarterly Report on Form 10-Q, as applicable to a smaller reporting company. Accordingly, they do not include all the information and footnotes required by US GAAP for complete financial statements.
The financial statements are unaudited; but in the opinion of management include all adjustments (consisting only of normal recurring adjustments) necessary for a fair presentation thereof. The balances as of June 30, 2019 have been derived from the audited consolidated financial statements. These financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto contained in the Annual Report on Form 10-K filed by the Company with the U.S. Securities and Exchange Commission on September 26, 2019. Certain items previously reported have been reclassified to conform to the current period’s reporting format. Such reclassifications did not affect net income or stockholders’ equity. The results of operations for the three months ended September 30, 2019 are not necessarily indicative of the results that may be expected for the six-month period ending December 31, 2019.
On August 21, 2019, the Company’s Board of Directors approved a change to the Company’s fiscal year end to December 31 from a fiscal year ending on June 30. As a result of the change in fiscal year, the Company will file a transition report on Form 10-KT covering the transition period from July 1, 2019 to December 31, 2019.
The Company has evaluated subsequent events through the date of issuance of the financial statements included herein.
Principles of Consolidation
The unaudited interim consolidated financial statements include accounts of the Company and its wholly-owned subsidiary, the Bank. All significant intercompany transactions and balances have been eliminated in consolidation.
7
Use of Estimates in the Preparation of Financial Statements
In preparing financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the Statement of Financial Condition and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the determination of the allowance for loan losses, other-than-temporary impairments of securities (“OTTI”), interest rate lock commitments (“IRLCs”), mandatory sales commitments, the valuation of mortgage loans held-for-sale and the valuation of deferred tax assets.
Recent Accounting Pronouncements
The Company qualifies under the Jumpstart Our Business Startups Act (the “JOBS Act”) as an emerging growth company. As an emerging growth company, the Company has elected to use the extended transition period to delay adoption of new or revised accounting pronouncements until such pronouncements are made applicable to private companies.
In June 2016, the FASB issued Accounting Standards Update (ASU) 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 requires credit losses on most financial assets measured at amortized cost and certain other instruments to be measured using an expected credit loss model (referred to as the current expected credit loss (CECL) model). Under this model, entities will estimate credit losses over the entire contractual term of the instrument (considering estimated prepayments, but not expected extensions or modifications unless reasonable expectation of a troubled debt restructuring exists) from the date of initial recognition of that instrument.
The ASU also replaces the current accounting model for purchased credit impaired loans and debt securities. The allowance for credit losses for purchased financial assets with a more-than insignificant amount of credit deterioration since origination (“PCD assets”), should be determined in a similar manner to other financial assets measured on an amortized cost basis. However, upon initial recognition, the allowance for credit losses is added to the purchase price (“gross up approach”) to determine the initial amortized cost basis. The subsequent accounting for PCD financial assets is the same expected loss model described above.
Further, the ASU made certain targeted amendments to the existing impairment model for available-for-sale (“AFS”) debt securities. For an AFS debt security for which there is neither the intent nor a more-likely-than-not requirement to sell, an entity will record credit losses as an allowance rather than a write-down of the amortized cost basis.
The ASU is effective for public business entities for fiscal years after December 15, 2019, including interim periods within those fiscal years. On October 16, 2019, the FASB decided to move forward with finalizing its proposal to defer the effective date for ASU 2016-13 for smaller reporting companies to fiscal years beginning after December 31, 2022, including interim periods within those fiscal periods. Since the Company currently meets the SEC definition of a smaller reporting company, the delay will be applicable to the Company. In anticipation of the ASU, the Company has entered into a contract with a third party, compiled data for the modeling and is working on developing an estimate using historically and qualitative data based on the requirements of ASU 2016-13.
In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework – Changes the Disclosure Requirements for Fair Value Measurements. The Update removes the requirement to disclose the amount of and reasons for transfers between Level I and Level II of the fair value hierarchy; the policy for timing of transfers between levels; and the valuation processes for Level III fair value measurements. The Update requires disclosure of changes in unrealized gains and losses for the period included in other comprehensive income (loss) for recurring Level III fair value
8
measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level III fair value measurements. This Update is effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. This Update is not expected to have a significant impact on the Company’s consolidated financial statements.
In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments – Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments, which affects a variety of topics in the Codification and applies to all reporting entities within the scope of the affected accounting guidance. Topic 326, Financial Instruments – Credit Losses amendments are effective for SEC registrants for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. For all other public business entities, the effective date is for fiscal years beginning after December 15, 2020, and for all other entities, the effective date is for fiscal years beginning after December 15, 2021. On October 16, 2019, the FASB voted to defer the effective date for ASC 326, Financial Instruments – Credit Losses, for smaller reporting companies to fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. The final ASU is expected to be issued in mid-November. Topic 815, Derivatives and Hedging amendments are effective for public business entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods beginning after December 15, 2020. For entities that have adopted the amendments in Update 2017-12, the effective date is as of the beginning of the first annual period beginning after the issuance of this Update. Topic 825, Financial Instruments amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years. The Company is currently evaluating the impact the adoption of the standard will have on the Company’s consolidated statements of financial position or statements of financial income.
Adoption of New Accounting Standards
In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). The standard requires lessees to recognize the assets and liabilities that arise from leases on the balance sheet. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. A short-term lease is defined as one in which (a) the lease term is 12 months or less and (b) there is not an option to purchase the underlying asset that the lessee is reasonably certain to exercise. For short-term leases, lessees may elect to recognize lease payments over the lease term on a straight-line basis. ASU 2016-02 was effective for the Company on July 1, 2019. In July 2018, the FASB issued ASU 2018-11, “Leases (Topic 842) - Targeted Improvements,” which, among other things, provides an additional transition method that would allow entities to not apply the guidance in ASU 2016-02 in the comparative periods presented in the financial statements and instead recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. In December 2018, the FASB also issued ASU 2018-20, “Leases (Topic 842) - Narrow-Scope Improvements for Lessors,” which provides for certain policy elections and changes lessor accounting for sales and similar taxes and certain lessor costs. Upon adoption of ASU 2016-02, ASU 2018-11 and ASU 2018-20 on July 1, 2019, we recognized a right-of-use asset of $2,106,100 and a related lease liability totaling $2,086,000 each. We elected to apply certain practical expedients provided under ASU 2016-02 whereby we did not reassess (i) whether any expired or existing contracts are or contain leases, (ii) the lease classification for any expired or existing leases and (iii) initial direct costs for any existing leases. We also elected not to apply the recognition requirements of ASU 2016-02 to any short-term leases (as defined by related accounting guidance). We account for lease and non-lease components separately because such amounts are readily determinable under our lease contracts. We utilized the modified-retrospective transition approach prescribed by ASU 2018-11. Certain of the Company’s leases contain options to renew the lease after the initial term. Management considers the Company’s historical pattern of exercising renewal options on leases and the positive performance of the leased locations, when determining whether it is reasonably certain that the leases will be renewed. If management concludes that there is reasonable certainty about the renewal it
9
is included in the calculation of the remaining term of each applicable lease. The discount rate utilized in calculating the present value of the remaining lease payments for each lease was the Federal Home Loan Bank of Pittsburgh advance rate corresponding to the remaining maturity of the lease as of July 1, 2019. We have included additional disclosures in note 12.
2. INVESTMENT SECURITIES
Investment securities available-for-sale was comprised of the following:
|
|
September 30, 2019
|
|
|
|
|
|
|
|
Gross
|
|
|
Gross
|
|
|
|
|
|
|
|
Amortized
|
|
|
Unrealized
|
|
|
Unrealized
|
|
|
|
|
|
(Dollars in thousands)
|
|
Cost
|
|
|
Gains
|
|
|
Losses
|
|
|
Fair Value
|
|
U.S. Governmental securities
|
|
$
|
456
|
|
|
$
|
2
|
|
|
$
|
(3
|
)
|
|
$
|
455
|
|
Corporate notes
|
|
|
6,000
|
|
|
|
79
|
|
|
|
(9
|
)
|
|
|
6,070
|
|
Collateralized mortgage obligations - agency
residential
|
|
|
5,578
|
|
|
|
3
|
|
|
|
(115
|
)
|
|
|
5,466
|
|
Mortgage-backed securities - agency
residential
|
|
|
2,225
|
|
|
|
9
|
|
|
|
(21
|
)
|
|
|
2,213
|
|
Municipal securities
|
|
|
4,376
|
|
|
|
2
|
|
|
|
—
|
|
|
|
4,378
|
|
Bank CDs
|
|
|
2,998
|
|
|
|
9
|
|
|
|
(1
|
)
|
|
|
3,006
|
|
|
|
$
|
21,633
|
|
|
$
|
104
|
|
|
$
|
(149
|
)
|
|
$
|
21,588
|
|
Investment securities available-for-sale was comprised of the following:
|
|
June 30, 2019
|
|
|
|
|
|
|
|
Gross
|
|
|
Gross
|
|
|
|
|
|
|
|
Amortized
|
|
|
Unrealized
|
|
|
Unrealized
|
|
|
|
|
|
(Dollars in thousands)
|
|
Cost
|
|
|
Gains
|
|
|
Losses
|
|
|
Fair Value
|
|
U.S. Governmental securities
|
|
$
|
478
|
|
|
$
|
—
|
|
|
$
|
(1
|
)
|
|
$
|
477
|
|
Corporate notes
|
|
|
6,960
|
|
|
|
44
|
|
|
|
(20
|
)
|
|
|
6,984
|
|
Collateralized mortgage obligations - agency
residential
|
|
|
8,818
|
|
|
|
31
|
|
|
|
(123
|
)
|
|
|
8,726
|
|
Mortgage-backed securities - agency
residential
|
|
|
3,468
|
|
|
|
9
|
|
|
|
(33
|
)
|
|
|
3,444
|
|
Municipal securities
|
|
|
11,915
|
|
|
|
207
|
|
|
|
(2
|
)
|
|
|
12,120
|
|
Bank CDs
|
|
|
3,497
|
|
|
|
—
|
|
|
|
(12
|
)
|
|
|
3,485
|
|
|
|
$
|
35,136
|
|
|
$
|
291
|
|
|
$
|
(191
|
)
|
|
$
|
35,236
|
|
The scheduled maturities of securities available-for-sale at September 30, 2019 were as follows:
|
|
September 30, 2019
|
|
|
|
Available-for-Sale
|
|
|
|
Amortized
|
|
|
|
|
|
(Dollars in thousands)
|
|
Cost
|
|
|
Fair Value
|
|
Due in one year or less
|
|
$
|
3,761
|
|
|
$
|
3,761
|
|
Due from one to five years
|
|
|
5,613
|
|
|
|
5,631
|
|
Due from after five to ten years
|
|
|
4,001
|
|
|
|
4,063
|
|
Due after ten years
|
|
|
8,258
|
|
|
|
8,133
|
|
|
|
$
|
21,633
|
|
|
$
|
21,588
|
|
Securities with a fair value of $9.4 million and $11.3 million at September 30, 2019 and June 30, 2019, respectively, were pledged to secure public deposits and for other purposes as required by law.
10
Proceeds from the sale of available-for-sale securities for the three months ended September 30, 2019 were $12.1 million. Gross realized gains on such sales were approximately $211,000 and gross realized losses were $0 for the three months ended September 30, 2019.
There were no sales of available-for-sale securities for the three months ended September 30, 2018.
The following tables summarize the unrealized loss positions of securities available-for-sale as of September 30, 2019 and June 30, 2019:
|
|
September 30, 2019
|
|
|
|
Less than 12 Months
|
|
|
12 Months or Longer
|
|
|
Total
|
|
|
|
Fair
|
|
|
Unrealized
|
|
|
Fair
|
|
|
Unrealized
|
|
|
Fair
|
|
|
Unrealized
|
|
(Dollars in thousands)
|
|
Value
|
|
|
Loss
|
|
|
Value
|
|
|
Loss
|
|
|
Value
|
|
|
Loss
|
|
Available-for-sale:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Governmental securities
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
230
|
|
|
$
|
(3
|
)
|
|
$
|
230
|
|
|
$
|
(3
|
)
|
Corporate notes
|
|
|
—
|
|
|
|
—
|
|
|
|
1,491
|
|
|
|
(9
|
)
|
|
|
1,491
|
|
|
|
(9
|
)
|
Collateralized mortgage obligations
|
|
|
—
|
|
|
|
—
|
|
|
|
4,995
|
|
|
|
(115
|
)
|
|
|
4,995
|
|
|
|
(115
|
)
|
Mortgage-backed securities
|
|
|
—
|
|
|
|
—
|
|
|
|
1,481
|
|
|
|
(21
|
)
|
|
|
1,481
|
|
|
|
(21
|
)
|
Municipal securities
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
Bank CDs
|
|
|
—
|
|
|
|
—
|
|
|
|
748
|
|
|
|
(1
|
)
|
|
|
748
|
|
|
|
(1
|
)
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
8,945
|
|
|
$
|
(149
|
)
|
|
$
|
8,945
|
|
|
$
|
(149
|
)
|
|
|
June 30, 2019
|
|
|
|
Less than 12 Months
|
|
|
12 Months or Longer
|
|
|
Total
|
|
|
|
Fair
|
|
|
Unrealized
|
|
|
Fair
|
|
|
Unrealized
|
|
|
Fair
|
|
|
Unrealized
|
|
(Dollars in thousands)
|
|
Value
|
|
|
Loss
|
|
|
Value
|
|
|
Loss
|
|
|
Value
|
|
|
Loss
|
|
Available-for-sale:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Governmental securities
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
477
|
|
|
$
|
(1
|
)
|
|
$
|
477
|
|
|
$
|
(1
|
)
|
Corporate notes
|
|
|
988
|
|
|
|
(12
|
)
|
|
|
1,942
|
|
|
|
(8
|
)
|
|
|
2,930
|
|
|
|
(20
|
)
|
Collateralized mortgage obligations
|
|
|
—
|
|
|
|
—
|
|
|
|
5,331
|
|
|
|
(123
|
)
|
|
|
5,331
|
|
|
|
(123
|
)
|
Mortgage-backed securities
|
|
|
—
|
|
|
|
—
|
|
|
|
1,592
|
|
|
|
(33
|
)
|
|
|
1,592
|
|
|
|
(33
|
)
|
Municipal securities
|
|
|
—
|
|
|
|
—
|
|
|
|
850
|
|
|
|
(2
|
)
|
|
|
850
|
|
|
|
(2
|
)
|
Bank CDs
|
|
|
—
|
|
|
|
—
|
|
|
|
2,985
|
|
|
|
(12
|
)
|
|
|
2,985
|
|
|
|
(12
|
)
|
|
|
$
|
988
|
|
|
$
|
(12
|
)
|
|
$
|
13,177
|
|
|
$
|
(179
|
)
|
|
$
|
14,165
|
|
|
$
|
(191
|
)
|
At September 30, 2019 and June 30, 2019, the investment portfolio included two U.S. Government securities, respectively, with total fair values of $455,000 and $477,000, respectively. Of these securities, one and two were in an unrealized loss position as of September 30, 2019 and June 30, 2019, respectively. These securities are zero risk weighted for capital purposes and are guaranteed for repayment of principal and interest. As of September 30, 2019 and June 30, 2019, management found no evidence of other-than-temporary (“OTTI”) on any of the U.S. Governmental securities in an unrealized loss position held in the investment securities portfolio. The Company has the ability to hold to maturity and more likely than not, will not be required to sell the securities before a recovery of the cost has occurred.
At September 30, 2019 and June 30, 2019, the investment portfolio included ten and twelve corporate notes, respectively with total fair values of $6.1 million and $7.0 million at the end of each of period, respectively. Of these securities, three and six were in an unrealized loss position as of September 30, 2019 and June 30, 2019, respectively. At the time of purchase and as of September 30, 2019 and June 30, 2019, these bonds in an unrealized loss position continue to maintain investment grade ratings. As of September 30, 2019 and June 30, 2019, management found no evidence of OTTI on any of the corporate notes held in the investment securities portfolio. The Company has the ability to hold to maturity and more likely than not, will not be required to sell the securities before a recovery of the cost has occurred.
11
At September 30, 2019 and June 30, 2019, the investment portfolio included twenty-nine and thirty-four collateralized mortgage obligations (“CMOs”) with total fair values of $5.5 million and $8.7 million, respectively. Of these securities, twenty-seven were in an unrealized loss position as of September 30, 2019 and June 30, 2019, respectively. The CMO portfolio is comprised of 100% agency (FHLMC, FNMA and GNMA) investment grade bonds. As of September 30, 2019 and June 30, 2019, management found no evidence of OTTI on any of the CMOs held in the investment securities portfolio. The Company has the ability to hold to maturity and more likely than not, will not be required to sell the securities before a recovery of the cost has occurred.
At September 30, 2019 and June 30, 2019, the investment portfolio included eleven and fourteen mortgage backed securities (“MBS”) with a total fair value of $2.2 million and $3.4 million, respectively. Of these securities, six and seven were in an unrealized loss position as of September 30, 2019 and June 30, 2019, respectively. The MBS portfolio is comprised of 100% agency (FHLMC, FNMA and GNMA) investment grade bonds. As of September 30, 2019 and June 30, 2019, management found no evidence of OTTI on any of the MBS held in the investment securities portfolio. The Company has the ability to hold to maturity and more likely than not, will not be required to sell the securities before a recovery of the cost has occurred.
At September 30, 2019 and June 30, 2019, the investment portfolio included ten and twenty-four municipal securities with a total fair value of $4.4 million and $12.1 million, respectively. Of these securities, one and two were in an unrealized loss position as of September 30, 2019 and June 30, 2019, respectively. The Company’s municipal portfolio issuers are located in Pennsylvania and at the time of purchase, and as of September 30, 2019 and June 30, 2019, continue to maintain investment grade ratings. As of September 30, 2019 and June 30, 2019, management found no evidence of OTTI on any of the municipal securities held in the investment securities portfolio. The Company has the ability to hold to maturity and more likely than not, will not be required to sell the securities before a recovery of the cost has occurred.
At September 30, 2019 and June 30, 2019, the investment portfolio included twelve and fourteen Bank Certificate of Deposits (“CDs”) with a total fair value of $3.0 million and $3.5 million, respectively. Of these securities, three and twelve were in an unrealized loss position as of September 30, 2019 and June 30, 2019, respectively. The Bank CDs are fully insured by the FDIC. As of September 30, 2019 and June 30, 2019, management found no evidence of OTTI on any of the Bank CDs held in the investment securities portfolio. The Company has the ability to hold to maturity and more likely than not, will not be required to sell the securities before a recovery of the cost has occurred.
3. EQUITY SECURITIES
During September 2018, the Company purchased an equity security for $500,000. As of September 30, 2019, the Company determined that the equity investment did not have a readily determinable fair value measure and is carrying the equity investment at cost, less impairment, adjusted for changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.
The following table presents the carrying amount of the Company’s equity investment at September 30, 2019:
|
|
2019
|
|
(dollars in thousands)
|
|
Year-to-date
|
|
|
Life-to-date
|
|
Amortized cost
|
|
$
|
500
|
|
|
$
|
500
|
|
Impairment
|
|
|
—
|
|
|
|
—
|
|
Observable price changes
|
|
|
—
|
|
|
|
—
|
|
Carrying value
|
|
$
|
500
|
|
|
$
|
500
|
|
12
At September 30, 2019, the Company performed a qualitative assessment considering impairment indictors to evaluate whether the investment was impaired and determined the investment was not impaired.
4. LOANS RECEIVABLE
Loans receivable were comprised of the following:
|
|
September 30,
|
|
|
June 30,
|
|
(Dollars in thousands)
|
|
2019
|
|
|
2019
|
|
Residential:
|
|
|
|
|
|
|
|
|
One-to-four family
|
|
$
|
202,613
|
|
|
$
|
201,526
|
|
Home equity and HELOCs
|
|
|
4,497
|
|
|
|
4,158
|
|
Commercial:
|
|
|
|
|
|
|
|
|
Commercial real estate
|
|
|
25,865
|
|
|
|
16,460
|
|
Commercial business
|
|
|
6,935
|
|
|
|
9,728
|
|
Construction
|
|
|
2,309
|
|
|
|
1,981
|
|
Consumer:
|
|
|
|
|
|
|
|
|
Medical education
|
|
|
6,190
|
|
|
|
6,506
|
|
Other
|
|
|
15
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
248,424
|
|
|
|
240,362
|
|
|
|
|
|
|
|
|
|
|
Less:
|
|
|
|
|
|
|
|
|
Unearned discounts, origination and commitment
fees and costs
|
|
|
1,491
|
|
|
|
1,606
|
|
Allowance for loan losses
|
|
|
(1,334
|
)
|
|
|
(1,182
|
)
|
|
|
|
|
|
|
|
|
|
|
|
$
|
248,581
|
|
|
$
|
240,786
|
|
In November 2017, the Bank entered into a loan purchase agreement with a broker to purchase a portfolio of private education loans made to American citizens attending American Medical Association (“AMA”) approved medical schools in Caribbean Nations. The broker serves as a lender, holder, program designer and developer, administrator, and secondary market for the loan portfolios they generate. At September 30, 2019, the balance of the private education loans was $6.2 million. The private student loans were made following a proven credit criteria and were underwritten in accordance with the Bank’s policies. At September 30, 2019, there were six loans with a balance of approximately $325,000 that are past due 90 days or more. The Company allocated increased allowance for loan loss provisions to the medical education loans for the three months ended September 30, 2019 primarily as a result of net charge-offs totaling $92,000.
Overdraft deposits are reclassified as other consumer and are included in the total loans on the statements of financial condition. Overdrafts were $15,000 and $3,000 at September 30, 2019 and June 30, 2019, respectively.
13
The following tables summarize the activity in the allowance for loan losses by loan class for the three months ended September 30, 2019 and 2018.
Allowance for Loan Losses
|
|
For the three months ended September 30, 2019
|
|
(Dollars in thousands)
|
|
Beginning
Balance
|
|
|
Charge-
offs
|
|
|
Recoveries
|
|
|
(Credit)
Provisions
|
|
|
Ending
Balance
|
|
|
Ending
Balance:
Individually
Evaluated
for
Impairment
|
|
|
Ending
Balance:
Collectively
Evaluated
for
Impairments
|
|
Residential:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
One-to-four family
|
|
$
|
711
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
8
|
|
|
$
|
719
|
|
|
$
|
—
|
|
|
$
|
719
|
|
Home equity and HELOCs
|
|
|
46
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(6
|
)
|
|
|
40
|
|
|
|
—
|
|
|
|
40
|
|
Commercial:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial real estate
|
|
|
99
|
|
|
|
—
|
|
|
|
—
|
|
|
|
29
|
|
|
|
128
|
|
|
|
—
|
|
|
|
128
|
|
Commercial business
|
|
|
108
|
|
|
|
—
|
|
|
|
—
|
|
|
|
9
|
|
|
|
117
|
|
|
|
13
|
|
|
|
104
|
|
Construction
|
|
|
8
|
|
|
|
—
|
|
|
|
—
|
|
|
|
1
|
|
|
|
9
|
|
|
|
—
|
|
|
|
9
|
|
Consumer:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical education
|
|
|
210
|
|
|
|
(93
|
)
|
|
|
1
|
|
|
|
203
|
|
|
|
321
|
|
|
|
—
|
|
|
|
321
|
|
Other
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,182
|
|
|
$
|
(93
|
)
|
|
$
|
1
|
|
|
$
|
244
|
|
|
$
|
1,334
|
|
|
$
|
13
|
|
|
$
|
1,321
|
|
Allowance for Loan Losses
|
|
For the three months ended September 30, 2018
|
|
(Dollars in thousands)
|
|
Beginning
Balance
|
|
|
Charge-
offs
|
|
|
Recoveries
|
|
|
(Credit)
Provisions
|
|
|
Ending
Balance
|
|
|
Ending
Balance:
Individually
Evaluated
for
Impairment
|
|
|
Ending
Balance:
Collectively
Evaluated
for
Impairments
|
|
Residential:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
One-to-four family
|
|
$
|
651
|
|
|
$
|
—
|
|
|
$
|
1
|
|
|
$
|
43
|
|
|
$
|
695
|
|
|
$
|
—
|
|
|
$
|
695
|
|
Home equity and HELOCs
|
|
|
39
|
|
|
|
—
|
|
|
|
—
|
|
|
|
2
|
|
|
|
41
|
|
|
|
—
|
|
|
|
41
|
|
Commercial:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial real estate
|
|
|
65
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(4
|
)
|
|
|
61
|
|
|
|
—
|
|
|
|
61
|
|
Commercial business
|
|
|
65
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(4
|
)
|
|
|
61
|
|
|
|
14
|
|
|
|
47
|
|
Construction
|
|
|
15
|
|
|
|
—
|
|
|
|
—
|
|
|
|
1
|
|
|
|
16
|
|
|
|
—
|
|
|
|
16
|
|
Consumer:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical education
|
|
|
35
|
|
|
|
—
|
|
|
|
—
|
|
|
|
22
|
|
|
|
57
|
|
|
|
—
|
|
|
|
57
|
|
Other
|
|
|
1
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(1
|
)
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
871
|
|
|
$
|
—
|
|
|
$
|
1
|
|
|
$
|
59
|
|
|
$
|
931
|
|
|
$
|
14
|
|
|
$
|
917
|
|
14
The Company maintains a general allowance for loan losses based on evaluating known and inherent risks in the loan portfolio, including management’s continuing analysis of the factors underlying the quality of the loan portfolio. These factors include changes in the size and composition of the loan portfolio, actual loan loss experience, and current and anticipated economic conditions. The reserve is an estimate based upon factors and trends identified by management at the time the financial statements are prepared. The Company allocated increased allowance for loan loss provisions to the medical education loans for the three months ended September 30, 2019 primarily as a result of net charge-offs totaling $92,000 and increase in the reserve for delinquent and non-accrual medical education loans.
The following tables summarize information in regards to the recorded investment in loans receivable by loan class as of September 30, 2019 and June 30, 2019:
September 30, 2019
|
|
Loans Receivable
|
|
(Dollars in thousands)
|
|
Ending
Balance
|
|
|
Ending
Balance:
Individually
Evaluated
for
Impairment
|
|
|
Ending
Balance:
Collectively
Evaluated
for
Impairment
|
|
Residential
|
|
|
|
|
|
|
|
|
|
|
|
|
One-to-four family
|
|
$
|
202,613
|
|
|
$
|
1,820
|
|
|
$
|
200,793
|
|
Home equity and HELOCs
|
|
|
4,497
|
|
|
|
295
|
|
|
|
4,202
|
|
Commercial
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial real estate
|
|
|
25,865
|
|
|
|
321
|
|
|
|
25,544
|
|
Commercial business
|
|
|
6,935
|
|
|
|
124
|
|
|
|
6,811
|
|
Construction
|
|
|
2,309
|
|
|
|
—
|
|
|
|
2,309
|
|
Consumer:
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical education
|
|
|
6,190
|
|
|
|
—
|
|
|
|
6,190
|
|
Other
|
|
|
15
|
|
|
|
—
|
|
|
|
15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
248,424
|
|
|
$
|
2,560
|
|
|
$
|
245,864
|
|
June 30, 2019
|
|
Loans Receivable
|
|
(Dollars in thousands)
|
|
Ending
Balance
|
|
|
Ending
Balance:
Individually
Evaluated
for
Impairment
|
|
|
Ending
Balance:
Collectively
Evaluated
for
Impairment
|
|
Residential
|
|
|
|
|
|
|
|
|
|
|
|
|
One-to-four family
|
|
$
|
201,526
|
|
|
$
|
1,725
|
|
|
$
|
199,801
|
|
Home equity and HELOCs
|
|
|
4,158
|
|
|
|
316
|
|
|
|
3,842
|
|
Commercial
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial real estate
|
|
|
16,460
|
|
|
|
325
|
|
|
|
16,135
|
|
Commercial business
|
|
|
9,728
|
|
|
|
131
|
|
|
|
9,597
|
|
Construction
|
|
|
1,981
|
|
|
|
—
|
|
|
|
1,981
|
|
Consumer:
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical education
|
|
|
6,506
|
|
|
|
—
|
|
|
|
6,506
|
|
Other
|
|
|
3
|
|
|
|
—
|
|
|
|
3
|
|
|
|
$
|
240,362
|
|
|
$
|
2,497
|
|
|
$
|
237,865
|
|
15
The following table summarizes information about impaired loans by loan portfolio class as of September 30, 2019 and June 30, 2019:
|
|
September 30, 2019
|
|
|
June 30, 2019
|
|
(Dollars in thousands)
|
|
Recorded
Investment
|
|
|
Unpaid
Principal
Balance
|
|
|
Related
Allowance
|
|
|
Recorded
Investment
|
|
|
Unpaid
Principal
Balance
|
|
|
Related
Allowance
|
|
With no related allowance recorded
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
One-to-four family
|
|
$
|
1,820
|
|
|
$
|
1,559
|
|
|
$
|
—
|
|
|
$
|
1,725
|
|
|
$
|
1,935
|
|
|
$
|
—
|
|
Home equity and HELOCs
|
|
|
295
|
|
|
|
314
|
|
|
|
—
|
|
|
|
316
|
|
|
|
331
|
|
|
|
—
|
|
Commercial:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial real estate
|
|
|
321
|
|
|
|
321
|
|
|
|
—
|
|
|
|
325
|
|
|
|
325
|
|
|
|
—
|
|
Consumer:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical education
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
2,436
|
|
|
|
2,194
|
|
|
|
—
|
|
|
|
2,366
|
|
|
|
2,591
|
|
|
|
—
|
|
With an allowance recorded
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial business
|
|
|
124
|
|
|
|
127
|
|
|
|
13
|
|
|
|
131
|
|
|
|
132
|
|
|
|
13
|
|
|
|
|
124
|
|
|
|
127
|
|
|
|
13
|
|
|
|
131
|
|
|
|
132
|
|
|
|
13
|
|
|
|
$
|
2,560
|
|
|
$
|
2,321
|
|
|
$
|
13
|
|
|
$
|
2,497
|
|
|
$
|
2,723
|
|
|
$
|
13
|
|
The following table presents additional information regarding the impaired loans for the three months ended September 30, 2019 and September 30, 2018:
|
|
Three Months Ended September 30,
|
|
|
|
2019
|
|
|
2018
|
|
(Dollars in thousands)
|
|
Average
Record
Investment
|
|
|
Interest
Income
Recognized
|
|
|
Average
Record
Investment
|
|
|
Interest
Income
Recognized
|
|
With no related allowance recorded
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
One-to-four family
|
|
$
|
1,544
|
|
|
$
|
—
|
|
|
$
|
1,427
|
|
|
$
|
—
|
|
Home equity and HELOCs
|
|
|
170
|
|
|
|
—
|
|
|
|
122
|
|
|
|
—
|
|
Commercial:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial real estate
|
|
|
363
|
|
|
|
12
|
|
|
|
418
|
|
|
|
11
|
|
Consumer:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical education
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
2,077
|
|
|
|
12
|
|
|
|
1,967
|
|
|
|
11
|
|
With an allowance recorded
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial business
|
|
|
136
|
|
|
|
2
|
|
|
|
158
|
|
|
|
2
|
|
|
|
|
136
|
|
|
|
2
|
|
|
|
158
|
|
|
|
2
|
|
|
|
$
|
2,213
|
|
|
$
|
14
|
|
|
$
|
2,125
|
|
|
$
|
13
|
|
16
If these loans were performing under the original contractual rate, interest income on such loans would
have increased approximately $30,000 and $21,000 for the three months ended September 30, 2019 and
2018, respectively.
The following table presents nonaccrual loans by classes of the loan portfolio as of September 30, 2019 and June 30, 2019:
|
|
September 30,
|
|
|
June 30,
|
|
(Dollars in thousands)
|
|
2019
|
|
|
2019
|
|
Residential:
|
|
|
|
|
|
|
|
|
One-to-four family
|
|
$
|
1,875
|
|
|
$
|
1,852
|
|
Home equity and HELOCs
|
|
|
295
|
|
|
|
316
|
|
Commercial:
|
|
|
|
|
|
|
|
|
Commercial real estate
|
|
|
—
|
|
|
|
—
|
|
Commercial business
|
|
|
—
|
|
|
|
—
|
|
Construction
|
|
|
—
|
|
|
|
—
|
|
Consumer:
|
|
|
|
|
|
|
|
|
Medical education
|
|
|
1,383
|
|
|
|
1,108
|
|
Other
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,553
|
|
|
$
|
3,276
|
|
Credit quality risk ratings include regulatory classifications of Special Mention, Substandard, Doubtful and Loss. Loans classified as Special Mention have potential weaknesses that deserve management’s close attention. If uncorrected, the potential weaknesses may result in deterioration of prospects for repayment. Loans classified substandard have a well-defined weakness or weaknesses that jeopardize the liquidation of the debt. They include loans that are inadequately protected by the current net worth and paying capacity of the obligor or of the collateral pledged, if any. Loans classified doubtful have all the weaknesses inherent in loans classified substandard with the added characteristic that collection or liquidation in full, on the basis of current conditions and facts, is highly improbable. Loans classified as a loss are considered uncollectible and are charged to the allowance for loan losses. Loans not classified are rated pass.
The following tables summarize the aggregate Pass and criticized categories of Special Mention, Substandard and Doubtful within the Company’s internal risk rating system as of September 30, 2019 and June 30, 2019:
|
|
September 30, 2019
|
|
|
|
|
|
|
|
Special
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in thousands)
|
|
Pass
|
|
|
Mention
|
|
|
Substandard
|
|
|
Doubtful
|
|
|
Total
|
|
Residential:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
One-to-four family
|
|
$
|
200,738
|
|
|
$
|
—
|
|
|
$
|
1,875
|
|
|
$
|
—
|
|
|
$
|
202,613
|
|
Home equity and HELOCs
|
|
|
4,202
|
|
|
|
—
|
|
|
|
295
|
|
|
|
—
|
|
|
|
4,497
|
|
Commercial:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial real estate
|
|
|
25,338
|
|
|
|
206
|
|
|
|
321
|
|
|
|
—
|
|
|
|
25,865
|
|
Commercial business
|
|
|
6,727
|
|
|
|
—
|
|
|
|
208
|
|
|
|
—
|
|
|
|
6,935
|
|
Construction
|
|
|
2,309
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
2,309
|
|
Consumer:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical education
|
|
|
4,807
|
|
|
|
—
|
|
|
|
1,383
|
|
|
|
—
|
|
|
|
6,190
|
|
Other
|
|
|
15
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
15
|
|
|
|
$
|
244,136
|
|
|
$
|
206
|
|
|
$
|
4,082
|
|
|
$
|
—
|
|
|
$
|
248,424
|
|
17
|
|
June 30, 2019
|
|
|
|
|
|
|
|
Special
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in thousands)
|
|
Pass
|
|
|
Mention
|
|
|
Substandard
|
|
|
Doubtful
|
|
|
Total
|
|
Residential:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
One-to-four family
|
|
$
|
199,674
|
|
|
$
|
—
|
|
|
$
|
1,852
|
|
|
$
|
—
|
|
|
$
|
201,526
|
|
Home equity and HELOCs
|
|
|
3,842
|
|
|
|
—
|
|
|
|
316
|
|
|
|
—
|
|
|
|
4,158
|
|
Commercial:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial real estate
|
|
|
15,927
|
|
|
|
208
|
|
|
|
325
|
|
|
|
—
|
|
|
|
16,460
|
|
Commercial business
|
|
|
9,503
|
|
|
|
—
|
|
|
|
225
|
|
|
|
—
|
|
|
|
9,728
|
|
Construction
|
|
|
1,981
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
1,981
|
|
Consumer:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical education
|
|
|
5,398
|
|
|
|
—
|
|
|
|
1,108
|
|
|
|
—
|
|
|
|
6,506
|
|
Other
|
|
|
3
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
3
|
|
|
|
$
|
236,328
|
|
|
$
|
208
|
|
|
$
|
3,826
|
|
|
$
|
—
|
|
|
$
|
240,362
|
|
The following tables present the segments of the loan portfolio summarized by aging categories as of September 30, 2019 and June 30, 2019:
|
|
September 30, 2019
|
|
(Dollars in thousands)
|
|
30-59
Days Past
Due
|
|
|
60-89
Days Past
Due
|
|
|
Greater
than 90
Days
|
|
|
Total Past
Due
|
|
|
Current
|
|
|
Total
Loans
Receivable
|
|
|
Loans
Receivable
>90 Days
and
Accruing
|
|
Residential:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
One-to-four family
|
|
$
|
767
|
|
|
$
|
—
|
|
|
$
|
983
|
|
|
$
|
1,750
|
|
|
$
|
200,863
|
|
|
$
|
202,613
|
|
|
$
|
—
|
|
Home equity and HELOCs
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
4,497
|
|
|
|
4,497
|
|
|
|
—
|
|
Commercial:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial real estate
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
25,865
|
|
|
|
25,865
|
|
|
|
—
|
|
Commercial business
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
6,935
|
|
|
|
6,935
|
|
|
|
—
|
|
Construction
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
2,309
|
|
|
|
2,309
|
|
|
|
—
|
|
Consumer:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical education
|
|
|
368
|
|
|
|
114
|
|
|
|
325
|
|
|
|
807
|
|
|
|
5,383
|
|
|
|
6,190
|
|
|
|
—
|
|
Other
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
15
|
|
|
|
15
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,135
|
|
|
$
|
114
|
|
|
$
|
1,308
|
|
|
$
|
2,557
|
|
|
$
|
245,867
|
|
|
$
|
248,424
|
|
|
$
|
—
|
|
18
|
|
June 30, 2019
|
|
(Dollars in thousands)
|
|
30-59
Days Past
Due
|
|
|
60-89
Days Past
Due
|
|
|
Greater
than 90
Days
|
|
|
Total Past
Due
|
|
|
Current
|
|
|
Total
Loans
Receivable
|
|
|
Loans
Receivable
>90 Days
and
Accruing
|
|
Residential:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
One-to-four family
|
|
$
|
321
|
|
|
$
|
179
|
|
|
$
|
1,407
|
|
|
$
|
1,907
|
|
|
$
|
199,619
|
|
|
$
|
201,526
|
|
|
$
|
—
|
|
Home equity and HELOCs
|
|
|
—
|
|
|
|
—
|
|
|
|
316
|
|
|
|
316
|
|
|
|
3,842
|
|
|
|
4,158
|
|
|
|
—
|
|
Commercial:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial real estate
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
16,460
|
|
|
|
16,460
|
|
|
|
—
|
|
Commercial business
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
9,728
|
|
|
|
9,728
|
|
|
|
—
|
|
Construction
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
1,981
|
|
|
|
1,981
|
|
|
|
—
|
|
Consumer:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical education
|
|
|
534
|
|
|
|
220
|
|
|
|
841
|
|
|
|
1,595
|
|
|
|
4,911
|
|
|
|
6,506
|
|
|
|
—
|
|
Other
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
3
|
|
|
|
3
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
855
|
|
|
$
|
399
|
|
|
$
|
2,564
|
|
|
$
|
3,818
|
|
|
$
|
236,544
|
|
|
$
|
240,362
|
|
|
$
|
—
|
|
The Company may grant a concession or modification for economic or legal reasons related to a borrower\'s financial condition that it would not otherwise consider resulting in a modified loan that is then identified as a troubled debt restructuring (“TDR”). The Company may modify loans through rate reductions, extensions of maturity, interest only payments, or payment modifications to better match the timing of cash flows due under the modified terms with the cash flows from the borrowers' operations. Loan modifications are intended to minimize the economic loss and to avoid foreclosure or repossession of the collateral. TDRs are considered impaired loans for purposes of calculating the Company's allowance for loan losses. TDRs are restored to accrual status when the obligation is brought current, has performed in accordance with the modified contractual terms for a reasonable period of time, generally six months, and the ultimate collectability of the total contractual principal and interest is no longer in doubt.
The Company may identify loans for potential restructure primarily through direct communication with the borrower and evaluation of the borrower's financial statements, revenue projections, tax returns, and credit reports. Even if the borrower is not presently in default, management will consider the likelihood that cash flow shortages, adverse economic conditions and negative trends may result in a payment default in the near future.
19
As of September 30, 2019 and June 30, 2019, the Company had two loans identified as TDRs totaling $266,000 and $275,000, respectively. At September 30, 2019 and June 30, 2019, the two TDRs were performing in compliance with their restructured terms and on accrual status. There were no modifications to loans classified as TDRs during the three months ended September 30, 2019. No additional loan commitments were outstanding to these borrowers at September 30, 2019 and June 30, 2019. At both September 30, 2019 and June 30, 2019, there was a specific reserve of $13,000 and $13,000 related to one TDR.
The following table details the Company’s TDRs that are on accrual status and non-accrual status at September 30, 2019:
|
|
As of September 30, 2019
|
|
|
|
Number
|
|
|
Accrual
|
|
|
Non-Accrual
|
|
|
|
|
|
(Dollars in thousands)
|
|
Of Loans
|
|
|
Status
|
|
|
Status
|
|
|
Total TDRs
|
|
Commercial real estate
|
|
|
1
|
|
|
$
|
142
|
|
|
$
|
—
|
|
|
$
|
142
|
|
Commercial business
|
|
|
1
|
|
|
|
124
|
|
|
|
—
|
|
|
|
124
|
|
Total
|
|
|
2
|
|
|
$
|
266
|
|
|
$
|
—
|
|
|
$
|
266
|
|
The following table details the Company’s TDRs that are on accrual status and non-accrual status at June 30, 2019:
|
|
As of June 30, 2019
|
|
|
|
Number
|
|
|
Accrual
|
|
|
Non-Accrual
|
|
|
|
|
|
(Dollars in thousands)
|
|
Of Loans
|
|
|
Status
|
|
|
Status
|
|
|
Total TDRs
|
|
Commercial real estate
|
|
|
1
|
|
|
$
|
144
|
|
|
$
|
—
|
|
|
$
|
144
|
|
Commercial business
|
|
|
1
|
|
|
|
131
|
|
|
|
—
|
|
|
|
131
|
|
Total
|
|
|
2
|
|
|
$
|
275
|
|
|
$
|
—
|
|
|
$
|
275
|
|
The carrying amount of residential mortgage loans in the process of foreclosure was $614,000 and $631,000 at September 30, 2019 and June 30, 2019, respectively.
20
5. DERIVATIVES AND RISK MANAGEMENT ACTIVITIES
The Company did not have any derivative instruments designated as hedging instruments or subject to master netting and collateral agreements as of September 30, 2019 and June 30, 2019. The following tables summarize the amounts recorded in the Company’s consolidated statements of financial condition for derivatives not designated as hedging instruments as of September 30, 2019 and June 30, 2019 (in thousands):
September 30, 2019
|
|
|
|
|
|
|
|
|
|
|
Asset Derivatives
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance Sheet
|
|
|
|
|
|
Notional
|
|
|
|
Presentation
|
|
Fair Value
|
|
|
Amount
|
|
Interest rate lock commitments
|
|
Mortgage banking derivatives
|
|
$
|
1,209
|
|
|
$
|
39,728
|
|
Forward loan sales commitments
|
|
Mortgage banking derivatives
|
|
|
599
|
|
|
|
16,636
|
|
To Be Announced securities ("TBAs")
|
|
Mortgage banking derivatives
|
|
|
15
|
|
|
|
11,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liability Derivatives
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance Sheet
|
|
|
|
|
|
Notional
|
|
|
|
Presentation
|
|
Fair Value
|
|
|
Amount
|
|
Interest rate lock commitments
|
|
Other liabilities
|
|
$
|
17
|
|
|
$
|
4,303
|
|
Forward loan sales commitments
|
|
Other liabilities
|
|
|
82
|
|
|
|
11,164
|
|
TBA securities
|
|
Other liabilities
|
|
|
70
|
|
|
|
25,250
|
|
June 30, 2019
|
|
|
|
|
|
|
|
|
|
|
Asset Derivatives
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance Sheet
|
|
|
|
|
|
Notional
|
|
|
|
Presentation
|
|
Fair Value
|
|
|
Amount
|
|
Interest rate lock commitments
|
|
Mortgage banking derivatives
|
|
$
|
1,100
|
|
|
$
|
36,969
|
|
Forward loan sales commitments
|
|
Mortgage banking derivatives
|
|
|
579
|
|
|
|
13,994
|
|
TBA securities
|
|
Mortgage banking derivatives
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
Liability Derivatives
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance Sheet
|
|
|
|
|
|
Notional
|
|
|
|
Presentation
|
|
Fair Value
|
|
|
Amount
|
|
Interest rate lock commitments
|
|
Other liabilities
|
|
$
|
54
|
|
|
$
|
8,120
|
|
Forward loan sales commitments
|
|
Other liabilities
|
|
|
24
|
|
|
|
4,800
|
|
TBA securities
|
|
Other liabilities
|
|
|
124
|
|
|
|
34,250
|
|
The following table summarizes the amounts recorded in the Company’s consolidated statements of income for derivative instruments not designated as hedging instruments for the three months ended September 30, 2019 and 2018 (in thousands):
|
|
|
|
Gain/(Loss)
|
|
|
|
Consolidated Statements of Income
|
|
Three Months Ended
|
|
|
|
Presentation
|
|
September 30, 2019
|
|
|
September 30, 2018
|
|
Interest rate lock commitments
|
|
Gain (loss) from derivative instruments
|
|
$
|
146
|
|
|
$
|
(344
|
)
|
Forward loan sales commitments
|
|
Loss from derivative instruments
|
|
|
(38
|
)
|
|
|
(58
|
)
|
TBA securities
|
|
Gain from derivative instruments
|
|
|
69
|
|
|
|
85
|
|
|
|
Total gain (loss) from derivative instruments
|
|
$
|
177
|
|
|
$
|
(317
|
)
|
21
6. FAIR VALUE PRESENTATION
The Company uses fair value measurements to record fair value adjustments to certain assets and liabilities and to determine fair value disclosures. The fair value of a financial instrument is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is best determined based upon quoted market prices. However, in many instances, there are no quoted market prices for the Company’s various financial instruments. In cases where quoted market prices are not available, fair values are based on estimates using present value or other valuation techniques. Those techniques are significantly affected by the assumptions used, including the discount rate and estimates of future cash flows. Accordingly, the fair value estimates may not be realized in an immediate settlement of the instrument.
Fair value guidance provides a consistent definition of fair value, which focuses on exit price in an orderly transaction (that is, not a forced liquidation or distressed sale) between market participants at the measurement date under current market conditions. If there has been a significant decrease in the volume and level of activity for the asset or liability, a change in valuation technique or the use of multiple valuation techniques may be appropriate. In such instances, determining the price at which willing market participants would transact at the measurement date under current market conditions depends on the facts and circumstances and requires the use of significant judgment. The fair value is determined at a reasonable point within the range that is most representative of fair value under current market conditions. Management uses its best judgment in estimating the fair value of the Company’s financial instruments; however, there are inherent weaknesses in any estimation technique. Therefore, for substantially all financial instruments, the fair value estimates herein are not necessarily indicative of the amounts the Company could have realized in sales transaction on the dates indicated. The estimated fair value amounts have been measured as of their respective year-ends, and have not been reevaluated or updated for purposes of these financial statements subsequent to those respective dates. As such, the estimated fair values of these financial instruments subsequent to the respective reporting dates may be different than the amounts reported at each year-end.
In accordance with this guidance, the Company groups its financial assets and financial liabilities generally measured at fair value in three levels, based on the markets in which the assets and liabilities are traded and the reliability of the assumptions used to determine fair value.
Level 1 – Valuation is based on unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 1 assets and liabilities generally include debt and equity securities that are traded in an active exchange market. Valuations are obtained from readily available pricing sources for market transactions involving identical assets or liabilities.
Level 2 – Valuation is based on inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly or indirectly. The valuation may be based on quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.
Level 3 – Valuation is based on unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which determination of fair value requires significant management judgment or estimation.
22
The following tables provide the fair value for assets required to be measured and reported at fair value on a recurring basis as of September 30, 2019 and June 30, 2019:
|
|
September 30, 2019
|
|
(Dollars in thousands)
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
Investment securities available-for-sale:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Governmental securities
|
|
$
|
—
|
|
|
$
|
455
|
|
|
$
|
—
|
|
|
$
|
455
|
|
Corporate notes
|
|
|
—
|
|
|
|
3,008
|
|
|
|
3,062
|
|
|
|
6,070
|
|
Collateralized mortgage obligations -
agency residential
|
|
|
—
|
|
|
|
5,466
|
|
|
|
—
|
|
|
|
5,466
|
|
Mortgage-backed securities - agency
residential
|
|
|
—
|
|
|
|
2,213
|
|
|
|
—
|
|
|
|
2,213
|
|
Municipal securities
|
|
|
—
|
|
|
|
4,378
|
|
|
|
—
|
|
|
|
4,378
|
|
Bank CDs
|
|
|
—
|
|
|
|
3,006
|
|
|
|
—
|
|
|
|
3,006
|
|
Loans held for sale
|
|
|
—
|
|
|
|
39,013
|
|
|
|
—
|
|
|
|
39,013
|
|
Forward loan sales commitments
|
|
|
—
|
|
|
|
599
|
|
|
|
—
|
|
|
|
599
|
|
TBA securities
|
|
|
—
|
|
|
|
15
|
|
|
|
—
|
|
|
|
15
|
|
Interest rate lock commitments
|
|
|
—
|
|
|
|
—
|
|
|
|
1,209
|
|
|
|
1,209
|
|
|
|
$
|
—
|
|
|
$
|
58,153
|
|
|
$
|
4,271
|
|
|
$
|
62,424
|
|
|
|
June 30, 2019
|
|
(Dollars in thousands)
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
Investment securities available-for-sale:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Governmental securities
|
|
$
|
—
|
|
|
$
|
477
|
|
|
$
|
—
|
|
|
$
|
477
|
|
Corporate notes
|
|
|
—
|
|
|
|
3,954
|
|
|
|
3,030
|
|
|
|
6,984
|
|
Collateralized mortgage obligations -
agency residential
|
|
|
—
|
|
|
|
8,726
|
|
|
|
—
|
|
|
|
8,726
|
|
Mortgage-backed securities - agency
residential
|
|
|
—
|
|
|
|
3,444
|
|
|
|
—
|
|
|
|
3,444
|
|
Municipal securities
|
|
|
—
|
|
|
|
12,120
|
|
|
|
—
|
|
|
|
12,120
|
|
Bank CDs
|
|
|
—
|
|
|
|
3,485
|
|
|
|
—
|
|
|
|
3,485
|
|
Loans held for sale
|
|
|
—
|
|
|
|
33,748
|
|
|
|
—
|
|
|
|
33,748
|
|
Forward loan sales commitments
|
|
|
—
|
|
|
|
579
|
|
|
|
—
|
|
|
|
579
|
|
TBA securities
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
Interest rate lock commitments
|
|
|
—
|
|
|
|
—
|
|
|
|
1,100
|
|
|
|
1,100
|
|
|
|
$
|
—
|
|
|
$
|
66,533
|
|
|
$
|
4,130
|
|
|
$
|
70,663
|
|
The following tables provide the fair value for liabilities required to be measured and reported at fair value on a recurring basis as of September 30, 2019 and June 30, 2019.
|
|
September 30, 2019
|
|
(Dollars in thousands)
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
Forward loan sales commitments
|
|
$
|
—
|
|
|
$
|
82
|
|
|
$
|
—
|
|
|
$
|
82
|
|
TBA securities
|
|
|
—
|
|
|
|
70
|
|
|
|
—
|
|
|
|
70
|
|
Interest rate lock commitments
|
|
|
—
|
|
|
|
—
|
|
|
|
17
|
|
|
|
17
|
|
Liabilities measured at fair value on a recurring basis at June 30, 2019 are summarized below.
|
|
June 30, 2019
|
|
(Dollars in thousands)
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
Forward loan sales commitments
|
|
$
|
—
|
|
|
$
|
24
|
|
|
$
|
—
|
|
|
$
|
24
|
|
TBA securities
|
|
|
—
|
|
|
|
124
|
|
|
|
—
|
|
|
|
124
|
|
Interest rate lock commitments
|
|
|
—
|
|
|
|
—
|
|
|
|
54
|
|
|
|
54
|
|
23
The following tables represent the change in the assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the three ended September 30, 2019 and 2018:
|
|
|
|
(Dollars in thousands)
|
|
Corporate
notes
|
|
|
IRLC-
Asset
|
|
|
IRLC-
Liability
|
|
Beginning Balance: July 1, 2019
|
|
$
|
3,030
|
|
|
$
|
1,100
|
|
|
$
|
(54
|
)
|
Total gains (unrealized):
|
|
|
|
|
|
|
|
|
|
|
|
|
Included in other comprehensive income
|
|
|
32
|
|
|
|
—
|
|
|
|
—
|
|
Total gains included in earnings and held at reporting date
|
|
|
—
|
|
|
|
109
|
|
|
|
37
|
|
Transfers in and/or out of Level 3
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
Ending Balance: September 30, 2019
|
|
$
|
3,062
|
|
|
$
|
1,209
|
|
|
$
|
(17
|
)
|
|
|
|
|
(Dollars in thousands)
|
|
Corporate
notes
|
|
|
IRLC-
Asset
|
|
|
IRLC-
Liability
|
|
Beginning Balance: July 1, 2018
|
|
$
|
494
|
|
|
$
|
642
|
|
|
$
|
(56
|
)
|
Total gains (unrealized):
|
|
|
|
|
|
|
|
|
|
|
|
|
Included in other comprehensive income
|
|
|
1
|
|
|
|
—
|
|
|
|
—
|
|
Total (losses) or gains included in earnings and held at reporting date
|
|
|
—
|
|
|
|
(366
|
)
|
|
|
22
|
|
Transfers in and/or out of Level 3
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
Ending Balance: September 30, 2018
|
|
$
|
495
|
|
|
$
|
276
|
|
|
$
|
(34
|
)
|
There were no assets measured at fair value on a nonrecurring basis at September 30, 2019 and June 30, 2019.
24
The following table provides the carrying amount for each class of assets and liabilities and the fair value for certain financial instruments that are not required to be measured or reported at fair value on the Consolidated Statements of Financial Condition as of September 30, 2019 and June 30, 2019:
|
|
|
|
|
|
|
|
|
|
Quoted
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prices in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Active
|
|
|
Significant
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Markets for
|
|
|
Other
|
|
|
Significant
|
|
|
|
|
|
|
|
|
|
|
|
Identical
|
|
|
Observable
|
|
|
Unobservable
|
|
September 30, 2019
|
|
Carrying
|
|
|
Estimated
|
|
|
Assets
|
|
|
Inputs
|
|
|
Inputs
|
|
(Dollars in thousands)
|
|
Amount
|
|
|
Fair Value
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
27,255
|
|
|
$
|
27,255
|
|
|
$
|
27,255
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Equity securities
|
|
|
500
|
|
|
|
500
|
|
|
|
—
|
|
|
|
—
|
|
|
|
500
|
|
Loans receivable, net (1)
|
|
|
248,581
|
|
|
|
249,840
|
|
|
|
—
|
|
|
|
—
|
|
|
|
249,840
|
|
Bank-owned life insurance
|
|
|
6,216
|
|
|
|
6,216
|
|
|
|
6,216
|
|
|
|
—
|
|
|
|
—
|
|
Restricted investment in bank stock
|
|
|
1,553
|
|
|
|
1,553
|
|
|
|
1,553
|
|
|
|
—
|
|
|
|
—
|
|
Accrued interest receivable
|
|
|
974
|
|
|
|
974
|
|
|
|
974
|
|
|
|
—
|
|
|
|
—
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deposits
|
|
$
|
284,576
|
|
|
$
|
284,722
|
|
|
$
|
204,718
|
|
|
$
|
80,004
|
|
|
$
|
—
|
|
Advances from the FHLB
|
|
|
27,000
|
|
|
|
27,147
|
|
|
|
—
|
|
|
|
27,147
|
|
|
|
—
|
|
Securities sold under agreements to
repurchase
|
|
|
2,104
|
|
|
|
2,104
|
|
|
|
2,104
|
|
|
|
—
|
|
|
|
—
|
|
Advances from borrowers for taxes and insurance
|
|
|
1,376
|
|
|
|
1,376
|
|
|
|
1,376
|
|
|
|
|
|
|
|
|
|
Accrued interest payable
|
|
|
42
|
|
|
|
42
|
|
|
|
42
|
|
|
|
—
|
|
|
|
—
|
|
Off-balance sheet:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commitment to extend credit
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) In accordance with the prospective adoption of ASU No. 2016-01, the fair value of the loans as of September 30, 2019 and June 30, 2019 were measured using an exit price notion.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prices in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Active
|
|
|
Significant
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Markets for
|
|
|
Other
|
|
|
Significant
|
|
|
|
|
|
|
|
|
|
|
|
Identical
|
|
|
Observable
|
|
|
Unobservable
|
|
June 30, 2019
|
|
Carrying
|
|
|
Estimated
|
|
|
Assets
|
|
|
Inputs
|
|
|
Inputs
|
|
(Dollars in thousands)
|
|
Amount
|
|
|
Fair Value
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
20,234
|
|
|
$
|
20,234
|
|
|
$
|
20,234
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Equity securities
|
|
|
500
|
|
|
|
500
|
|
|
|
—
|
|
|
|
—
|
|
|
|
500
|
|
Loans receivable, net (1)
|
|
|
240,786
|
|
|
|
241,012
|
|
|
|
—
|
|
|
|
—
|
|
|
|
241,012
|
|
Bank-owned life insurance
|
|
|
6,175
|
|
|
|
6,175
|
|
|
|
6,175
|
|
|
|
—
|
|
|
|
—
|
|
Restricted investment in bank stock
|
|
|
1,662
|
|
|
|
1,662
|
|
|
|
1,662
|
|
|
|
—
|
|
|
|
—
|
|
Accrued interest receivable
|
|
|
1,111
|
|
|
|
1,111
|
|
|
|
1,111
|
|
|
|
—
|
|
|
|
—
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deposits
|
|
$
|
275,130
|
|
|
$
|
275,297
|
|
|
$
|
193,793
|
|
|
$
|
81,504
|
|
|
$
|
—
|
|
Advances from the FHLB
|
|
|
28,000
|
|
|
|
28,169
|
|
|
|
—
|
|
|
|
28,169
|
|
|
|
—
|
|
Securities sold under agreements to
repurchase
|
|
|
3,789
|
|
|
|
3,789
|
|
|
|
3,789
|
|
|
|
—
|
|
|
|
—
|
|
Advances from borrowers for taxes and insurance
|
|
|
2,600
|
|
|
|
2,600
|
|
|
|
2,600
|
|
|
|
—
|
|
|
|
—
|
|
Accrued interest payable
|
|
|
219
|
|
|
|
219
|
|
|
|
219
|
|
|
|
—
|
|
|
|
—
|
|
Off-balance sheet:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commitment to extend credit
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
25
The above information should not be interpreted as an estimate of the fair value of the entire Company since a fair value calculation is only provided for a limited portion of the Company’s assets and liabilities. Due to a wide range of valuation techniques and the degree of subjectivity used in making the estimates, comparisons between the Company’s disclosures and those of other companies may not be meaningful. There were no changes in methodologies or transfers between levels at September 30, 2019. During June 2019, the Company transferred corporate note securities, amortized cost of $2.5 million, to the available-for-sale portfolio from the held-to-maturity portfolio. There was no change of the Level 3 valuation when the corporate securities were transferred.
The following methods and assumptions were used to estimate the fair values of the Company’s financial instruments at June 30, 2019:
Cash and Cash Equivalents
These short-term assets are valued at their face value, which approximate fair value.
Investments (Available- for- Sale and Held- to- Maturity)
Where quoted prices are available in an active market for identical instruments, investment securities are classified within Level 1 of the valuation hierarchy. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics, or discounted cash flows. Such instruments, which would generally be classified within Level 2 of the valuation hierarchy, include certain Mortgage Backed Securities (MBS), Collateralized Mortgage Obligations (CMO), Corporate notes, and Municipal and U.S government securities. In cases where there is limited activity or less transparency around inputs to the valuation, investment securities are classified within Level 3 of the valuation hierarchy. Investment securities classified within Level 3 include certain equity securities that do not have readily available market prices, certain corporate notes, certain Bank CDS and other less liquid investment securities. If observable market-based inputs are not available, we use unobservable inputs to determine appropriate valuation adjustments by reviewing valuation reports provided by a third-party (Level 3).
Loans Held for Sale at Fair Value
All mortgage loans held for sale are carried at fair value which is determined on a recurring basis by utilizing quoted prices from dealers in such loans.
The Company's mortgage loans held for sale are generally classified within Level 2 of the valuation hierarchy.
The following table reflects the difference between the carrying amount of mortgage loans held for sale, measured at fair value and the aggregate unpaid principal amount that the Company is contractually entitled to receive at maturity as of June 30, 2019 (in thousands):
Loans held for sale
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Carrying Amount
|
|
|
Aggregated Unpaid Principal Balance
|
|
|
Excess Carrying
Amount Over
Aggregate Unpaid
Principal Balance
|
|
June 30, 2019
|
|
$
|
33,748
|
|
|
$
|
33,045
|
|
|
$
|
703
|
|
The Company did not have any mortgage loans held for sale recorded at fair value that were 90 or more days past due and on non-accrual at September 30, 2019 or June 30, 2019.
26
Interest Rate Lock Commitments (“IRLC”)
The fair value of the Company’s IRLC instruments are based upon the underlying mortgage loan adjusted for the probability of such commitments being exercised and estimated costs to complete and originate the loan. The Company’s IRLCs are classified within Level 3 of the valuation hierarchy as a result of unobservable market data inputs.
Forward Loan Sale Commitments
Fair values for forward loan sales commitments are based on forward prices with dealers in such securities. Due to the observable inputs used by the Company, the Company’s forward loan sales commitments are classified within Level 2 of the valuation hierarchy.
To Be Announced Securities (“TBAs”)
TBAs are valued based on forward dealer marks from the Company’s approved counterparties. The Company utilizes a third party market pricing service which compiles current prices for instruments from market sources, and those prices represent the current executable price. Due to the observable inputs used by the Company, the Company’s TBAs are classified within Level 2 of the valuation hierarchy.
Loan Receivable, Net
Fair values are estimated for portfolios of loans with similar financial characteristics. For loans that reprice frequently, the carrying value approximates fair value. The fair value of other type of loans is estimated by discounting expected cash flows using the current rates at which similar loans would be made to borrowers with comparable credit ratings and for similar remaining maturities.
Impaired Loans
The Company has measured impairment on impaired loans generally based on the fair value of the loan's collateral. The fair value of collateral is based on appraisals performed by qualified licensed appraisers hired by the Company. In some cases, management may adjust the appraised value due to the age of the appraisal, changes in market conditions, or observable deterioration of the property since the appraisal was completed. Additionally, management makes estimates about expected costs to sell the property which are also included in the net realizable value. If the fair value of the collateral dependent loan is less than the carrying amount of the loan a specific reserve for the loan is made in the allowance for loan losses or a charge-off is taken to reduce the loan to the fair value of the collateral (less estimated selling costs) and the loan is included as a Level III measurement. At September 30, 2019 and June 30, 2019, the fair value of the collateral exceeded the carrying amount of the loan; therefore, there are no impaired loans currently being carried at its fair value.
Bank-Owned Life Insurance
The carrying amount of the investment in bank-owned life insurance approximates its cash surrender value under the insurance policies.
Restricted Investment in Bank Stock
The stock is carried at cost; which approximates fair value and considers the limited marketability of such securities.
Accrued Interest Receivable and Accrued Interest Payable
The carrying amount of accrued interest receivable and payable approximates their respective fair values.
27
Deposits
The carrying amount of demand deposits, savings accounts and money market deposits approximate their fair value. The discount rate is estimated using the rates currently offered for deposits with comparable remaining maturities. The fair value of certificates of deposit is estimated discounting the contractual cash flows. The discount rate is estimated using the rates currently offered for deposits with comparable remaining maturities.
Advances from the FHLB
The fair value of advances is estimated based on the discounted value of contractual cash flows. The discount rate is estimated using the rates currently offered for borrowings with comparable terms, credit, and remaining maturities.
Securities Sold Under Agreements to Repurchase
Securities sold under agreements to repurchase are carried at the amounts at which the securities will be subsequently repurchased as specified in the agreements and the carrying amount is a reasonable estimate of the fair value. The Company values the collateral on a daily basis and obtains additional collateral, if necessary, to protect the Company in the event of default by the counterparties.
Advances from Borrowers for Taxes and Insurance
The carrying amount of advances from borrowers for taxes and insurance approximates fair values.
Commitments to Extend Credit
The majority of the Company's commitments to extend credit carry current market interest rates if converted to loans. Because commitments to extend credit are generally unassignable by either the Company or the borrower, they only have value to the Company and the borrower. The fair value of commitments to extend credit is estimated using the fees currently charged to enter into similar agreements, taking into account the remaining terms of the agreements and the present creditworthiness of the counterparties and is not considered material for disclosure.
7. CHANGES IN AND RECLASSIFICATIONS OUT OF ACCUMULATED OTHER COMPREHENSIVE LOSS
The following tables present the changes in the balances of each component of accumulated other comprehensive income (“AOCI”) for the three months ended September 30, 2019 and September 30, 2018. All amounts are presented net of tax.
Net unrealized holding gains on available-for-sales securities (1):
|
|
|
|
|
|
|
|
|
|
|
For the three months ended
|
|
(Dollars in thousands)
|
|
September 30, 2019
|
|
|
September 30, 2018
|
|
Balance at beginning period
|
|
$
|
70
|
|
|
$
|
(648
|
)
|
Unrealized holding gain (losses) on available-for-sale securities before reclassification
|
|
|
61
|
|
|
|
(86
|
)
|
Amount reclassified for investment
securities gains included in net income
|
|
|
(162
|
)
|
|
|
—
|
|
Net current-period other comprehensive loss
|
|
|
(101
|
)
|
|
|
(86
|
)
|
Balance at ending period
|
|
$
|
(31
|
)
|
|
$
|
(734
|
)
|
|
|
|
|
|
|
|
|
|
28
|
(1)
|
All amounts are net of tax. Related tax expense or benefit is calculated using an income tax rate of approximately 29.9% and 29.5% for the three months ended September 30, 2019 and 2018, respectively.
|
The following table present reclassifications out of AOCI by component for the three months ended September 30, 2019 and September 30, 2018.
|
|
For the three months ended September 30, 2019
|
|
|
For the three months ended September 30, 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in thousands)
|
|
Amount reclassified
from accumulated
other comprehensive
income (2)
|
|
|
Amount reclassified
from accumulated
other comprehensive
income (2)
|
|
Affected line item in the consolidated statements of income
|
Net unrealized gain on available-for securities (1)
|
|
$
|
211
|
|
|
$
|
—
|
|
Gain on sale of
available-for-sale
securities, net
|
|
|
|
(49)
|
|
|
|
—
|
|
Income tax expense
|
|
|
$
|
162
|
|
|
$
|
—
|
|
|
|
(1)
|
For additional details related to unrealized gains on investment securities and related amounts reclassified from accumulated other comprehensive loss, See Note 2, “Investment securities.”
|
|
(2)
|
Amounts in parentheses indicate debits.
|
8. EARNINGS PER SHARE
Earnings per share ("EPS") consist of two separate components: basic EPS and diluted EPS. Basic EPS is computed by dividing net income by the weighted average number of common shares outstanding for each period presented. The diluted EPS calculation reflects the EPS if all outstanding instruments convertible to common stock were exercised. The computation of diluted earnings per share does not assume conversion, exercise or contingent exercise of securities that would have an anti-dilutive effect. At September 30, 2019, there were 218,000 stock options outstanding of which 30,080 of the stock options were vested and exercisable at September 30, 2019. At September 30, 2019, there 87,000 restricted stock shares outstanding of which 11,680 restricted stock shares were vested and exercisable at September 30, 2019. The 218,000 stock options outstanding and 87,000 restricted stock shares outstanding were not included in the computation of diluted net income per share for the three months ended September 30, 2019 as their effect would have been anti-dilutive. At September 30, 2018, there were 198,000 stock options outstanding and 77,000 restricted stock shares outstanding which none of the stock options and restricted stock shares were vested and exercisable at September 30, 2018. The 198,000 stock options outstanding were not included in the computation of diluted net income per share for the three months ended September 30, 2018, as their effect would have been anti-dilutive.
29
The calculation of basic and diluted EPS for the three months ended September 30, 2019 and 2018 is as follows:
|
|
For the Three Months
Ended September 30
|
|
|
|
2019
|
|
|
2018
|
|
Net income
|
|
$
|
333,000
|
|
|
$
|
270,000
|
|
Weighted average number of shares issued
|
|
|
2,269,125
|
|
|
|
2,259,125
|
|
Less weighted average number of treasury shares
|
|
|
(208
|
)
|
|
|
—
|
|
Less weighted average number of unearned ESOP shares
|
|
|
(151,326
|
)
|
|
|
(164,096
|
)
|
Less weighted average number of unvested restricted stock awards
|
|
|
(73,288
|
)
|
|
|
(75,207
|
)
|
Basic weighted average shares outstanding
|
|
|
2,044,303
|
|
|
|
2,019,822
|
|
Add dilutive effect of stock options
|
|
|
—
|
|
|
|
—
|
|
Add dilutive effect of restricted stock awards
|
|
|
—
|
|
|
|
347
|
|
Diluted weighted average shares outstanding
|
|
|
2,044,303
|
|
|
|
2,020,169
|
|
|
|
|
|
|
|
|
|
|
Net income per share:
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.16
|
|
|
$
|
0.13
|
|
Diluted
|
|
$
|
0.16
|
|
|
$
|
0.13
|
|
9. EMPLOYEE BENFITS
Equity Incentive Plan
The Company’s shareholders approved the HV Bancorp, Inc. 2018 Equity Incentive Plan (the “2018 Equity Incentive Plan”) at a Special Meeting of shareholders on June 13, 2018. An aggregate of 305,497 shares of authorized but unissued common stock of the Company was reserved for future grants of incentive and non-qualified stock options, restricted stock awards and restricted stock units under the 2018 Equity Incentive Plan. Of the 305,497 authorized shares, the maximum number of shares of the Company’s common stock that may be issued under the 2018 Equity Incentive Plan pursuant to the exercise of stock options is 218,212 shares, and the maximum number of shares of the Company’s common stock that may be issued as restricted stock awards or restricted stock units is 87,285 shares.
The product of the number of shares granted and the grant date market price of the Company’s common stock determine the fair value of restricted stock under the Company’s 2018 Equity Incentive plan. Management recognizes compensation expense for the fair value of restricted stock on a straight-line basis over the requisite service period for the entire award. As of September 30, 2019, there were 497 shares available for future awards under this plan, which includes 212 shares available for incentive and non-qualified stock options and 285 shares available for restricted stock awards. The restricted shares and stock options vest over a seven year period.
Stock option expense was $15,000 and $18,000 for the three months ended September 30, 2019 and September 30, 2018, respectively. At September 30, 2019, total unrecognized compensation cost related to stock options was $353,000.
30
A summary of the Company’s stock option activity and related information for the three months ended September 30, 2019 and September 30, 2018 was as follows:
|
|
2019
|
|
|
2018
|
|
|
|
Options
|
|
|
Weighted-
Average
Exercise Price
|
|
|
Weighted-
Average
Remaining Contractual Life (in years)
|
|
|
Average
Intrinsic Value
|
|
|
Options
|
|
|
Weighted-
Average
Exercise Price
|
|
|
Weighted-
Average
Remaining Contractual Life (in years)
|
|
|
Average
Intrinsic Value
|
|
Outstanding, July 1
|
|
|
218,000
|
|
|
$
|
14.92
|
|
|
|
9.1
|
|
|
$
|
61,040
|
|
|
|
198,000
|
|
|
$
|
14.80
|
|
|
|
10.0
|
|
|
$
|
3,960
|
|
Granted
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
Exercised
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
Forfeited
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
Outstanding, September 30
|
|
|
218,000
|
|
|
$
|
14.92
|
|
|
|
8.8
|
|
|
$
|
—
|
|
|
|
198,000
|
|
|
$
|
14.80
|
|
|
|
9.7
|
|
|
$
|
3,960
|
|
Exercisable, September 30
|
|
|
30,080
|
|
|
$
|
14.80
|
|
|
|
8.7
|
|
|
$
|
—
|
|
|
|
—
|
|
|
$
|
—
|
|
|
|
—
|
|
|
$
|
—
|
|
Restricted stock expense for the three months ended September 30, 2019 and September 30, 2018 was $46,000, respectively. At September 30, 2019, the expected future compensation expense relating to non-vested restricted stock outstanding was $1.1 million.
A summary of the Company’s restricted stock activity and related information for the three months ended September 30, 2019 and 2018 was as follows:
|
|
2019
|
|
|
2018
|
|
|
|
Number of
Shares
|
|
|
Weighted-
Average Grant
Date Fair Value
|
|
|
Number of
Shares
|
|
|
Weighted-
Average Grant
Date Fair Value
|
|
Non-vested, July 1
|
|
|
75,320
|
|
|
$
|
14.97
|
|
|
|
77,000
|
|
|
$
|
14.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
Forfeited
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
Non-vested at September 30
|
|
|
75,320
|
|
|
$
|
14.97
|
|
|
|
77,000
|
|
|
$
|
14.80
|
|
10. RELATED PARTY TRANSACTIONS
In November 2017, the Company engaged a third party to provide services for certain customers with large deposit balances, by offering both a competitive rate of return and FDIC insurance. Related party balances in this program totaled $19.1 million at September 30, 2019 for which the Company received fees for customer services totaling approximately $7,000 and $37,000 in the three months ended September 30, 2019 and September 30, 2018, respectively.
In January 2018, the Company entered into a business consulting agreement with one of our directors to provide deposit sales training, grow deposit market share and identify deposit opportunities. This agreement will terminate on December 31, 2019. The Company has paid $15,000 in consulting fees to the director for three months ended September 30, 2019 and September 30, 2018, respectively.
11. REVENUE RECOGNITION
On July 1, 2018, the Company adopted ASU No. 2014-09 “Revenue from Contracts with Customers” (Topic 606) and all subsequent ASUs that modified Topic 606. The implementation of the new standard did not have a material impact on the measurement or recognition of revenue; as such, a cumulative effect adjustment to opening retained earnings was not deemed necessary. Results for reporting periods
31
beginning after July 1, 2018 are presented under Topic 606, while prior period amounts were not adjusted and continue to be reported in accordance with our historic accounting under Topic 605.
Topic 606 does not apply to revenue associated with financial instruments, including revenue from loans and securities. In addition, certain noninterest income streams such as income from bank owned life insurance, sales of investment securities, mortgage banking activities, and certain items within other income are also not in scope of the new guidance. Topic 606 is applicable to noninterest revenue streams such deposit related fees, interchange fees, and fees income received in exchange for customer’s deposits sourced with a deposit placement network. However, the recognition of these revenue streams did not change significantly upon adoption of Topic 606.
The following table presents noninterest income for the three months ended September 30, 2019 and 2018:
|
|
Three Months Ended
September 30,
|
|
(Dollars in thousands)
|
|
2019
|
|
|
2018
|
|
Non-Interest Income
|
|
|
|
|
|
|
|
|
In-scope of Topic 606:
|
|
|
|
|
|
|
|
|
Fee income
|
|
$
|
13
|
|
|
$
|
39
|
|
Insufficient fund fees
|
|
|
15
|
|
|
|
16
|
|
Other service charges
|
|
|
21
|
|
|
|
15
|
|
ATM interchange fee income
|
|
|
2
|
|
|
|
2
|
|
Total Non-Interest Income (in-scope of Topic 606)
|
|
$
|
51
|
|
|
$
|
72
|
|
|
|
|
|
|
|
|
|
|
Out-of-scope of Topic 606:
|
|
|
|
|
|
|
|
|
Increase in cash surrender value of bank-owned life insurance
|
|
$
|
41
|
|
|
$
|
40
|
|
Gain on sale of loans, net
|
|
|
1,680
|
|
|
|
901
|
|
Gain on sale of available-for-sale securities
|
|
|
211
|
|
|
|
—
|
|
Gain (loss) from derivative instruments
|
|
|
177
|
|
|
|
(317
|
)
|
Change in fair value for loans held-for-sale
|
|
|
40
|
|
|
|
61
|
|
Other
|
|
|
5
|
|
|
|
1
|
|
Total Non-Interest Income (out-scope of Topic 606)
|
|
|
2,154
|
|
|
|
686
|
|
Total Non-Interest Income (in-scope of Topic 606)
|
|
|
51
|
|
|
|
72
|
|
Total Noninterest Income
|
|
$
|
2,205
|
|
|
$
|
758
|
|
The following is a discussion of key revenues of fees for customer services that are within the scope of the new revenue guidance:
32
• Fee income – Fee income primarily consists of a fee received for placing customer deposits in a deposit placement network such that amounts are under the standard FDIC insurance maximum of $250,000 making the deposits eligible for FDIC insurance. The Company acts as an intermediary between the customer and the deposit placement network. The Company’s performance obligation is generally satisfied upon placement of the customer’s deposit in deposit placement network.
• Insufficient fund fees and other service charges– Revenue from service charges on deposit accounts is earned through cash management, wire transfer, and other deposit-related services; as well as overdraft, non-sufficient funds, account management and other deposit-related fees. Revenue is recognized for these services either over time, corresponding with deposit accounts’ monthly cycle, or at a point in time for transactional related services and fees. These revenues are included in insufficient funds fees and other service charges in the table above.
• ATM interchange and fee income – ATM fees are primarily generated when a Company cardholder uses a non-Company ATM or a non-Company cardholder used a Company’s ATM. The Company’s performance obligation for ATM fee income are largely satisfied, and related
revenue recognized, when the services are rendered or upon completion.
|
12. Leases
A lease is defined as a contract, or part of a contract, that conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. On July 1, 2019, the Company adopted ASU No. 2016-02 “Leases” (Topic 842) and all subsequent ASUs that modified Topic 842. For the Company, Topic 842 primarily affected the accounting treatment for operating lease agreements in which the Company is the lessee. Upon adoption of ASC Topic 842, Leases, on July 1, 2019, the Company recorded an asset of $2.1 million and a corresponding liability in the amount of $2.1 million, included in other assets and other liabilities on the consolidated statement of financial condition. The Company recorded an additional asset of $3.7 million and a corresponding liability in the amount of $3.7 million during the three months ended September 30, 2019 for two new lease agreements. In addition, as part of the adoption of Topic 842 on July 1, 2019, the Company booked an adjustment of $277,000 to retained earnings to write-off the balance of the deferred gain on sale-leaseback of buildings. The Company elected to adopt the transition relief under ASC Topic 842 using the modified retrospective transition method. All lease agreements are accounted for as operating leases. The Company has no unamortized initial direct costs related to the establishment of these lease agreements as of July 1, 2019.
Lessee Accounting
Substantially all of the leases in which the Company is the lessee are comprised of real estate property for branches and office spaces with terms extending through 2036. All of our leases are classified as operating leases, and therefore, were previously not recognized on the Company’s consolidated statements of financial condition. With the adoption of Topic 842, operating lease agreements are required to be recognized on the consolidated statements of financial condition as a right-of-use (“ROU”) asset and a corresponding lease liability.
The following table represents the consolidated statements of financial condition classification of the Company’s ROU assets and lease liabilities. The Company elected not to include short-term leases (i.e., leases with initial terms of twelve months or less) on the consolidated statements of financial condition.
|
|
|
September 30, 2019
|
|
Lease Right-of-Use Assets
|
|
Classification
|
|
|
|
Operating lease right-of-use assets
|
|
Other assets
|
$
|
5,783
|
|
Total Lease Right-of-Use Assets
|
|
|
$
|
5,783
|
|
|
|
|
September 30, 2019
|
|
Lease Liabilities
|
|
Classification
|
|
|
|
Operating lease liabilities
|
|
Other liabilities
|
$
|
5,757
|
|
Total Lease Liabilities
|
|
|
$
|
5,757
|
|
The calculated amount of the ROU assets and lease liabilities in the table above are impacted by the length of the lease term and the discount rate used to present value the minimum lease payments. The Company’s lease agreements often include one or more options to renew at the Company’s discretion. If at lease inception, the Company considers the exercising of a renewal option to be reasonably certain, the Company will include the extended term in the calculation of the ROU asset and lease liability. Regarding the discount rate, Topic 842 requires the use of the rate implicit in the lease whenever this rate is readily determinable. The Company utilized its incremental borrowing rate at lease inception, on a collateralized basis, over a similar term as the rate implicit in the lease was not readily determinable. For operating leases existing prior to July 1, 2019, the rate for the remaining lease term as of July 1, 2019 was used.
33
|
|
|
September 30, 2019
|
|
Weighted-average remaining lease term
|
|
|
|
|
|
Operating leases
|
|
|
13.3 years
|
|
Weighted-average discount rate
|
|
|
|
|
|
Operating leases
|
|
|
|
2.35
|
%
|
The components of the lease expense are as follows:
(dollars in thousands)
|
For the three months ended September 30, 2019
|
|
Operating lease cost
|
$
|
73
|
|
Short-term lease cost
|
|
63
|
|
Total
|
$
|
136
|
|
Future minimum payments for operating leases with initial or remaining terms of one year or more as of September 30, 2019 were as follows:
(dollars in thousands)
|
Operating Leases
|
|
Twelve Months Ended:
|
|
|
|
9/30/2020
|
$
|
317
|
|
9/30/2021
|
|
564
|
|
9/30/2022
|
|
529
|
|
9/30/2023
|
|
524
|
|
9/30/2024
|
|
529
|
|
2025 and thereafter
|
|
4,298
|
|
Total Future Minimum Lease Payments
|
|
6,761
|
|
Amounts Representing Interest
|
|
(1,004
|
)
|
Present Value of Net Future Minimum Lease Payments
|
$
|
5,757
|
|
34